News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


PD-1 blockade enhances the vaccination induced immune response in glioma

Al's Comment:

 This combination of vaccine and checkpoint inhibitor worked much better than either alone, at least in mice. Hopefully they can move this to patients quickly, as the checkpoint inhibitor is already FDA approved for other diseases and they are already running a trial of the vaccine.

By the way - they acknowledge the Musella Foundation For Brain Tumor Research & Information, Inc  as a source of funding!  This is your donations at work!

Posted on: 07/21/2016

PD-1 blockade enhances the vaccinationinduced immune response in glioma

Click here for the full text PDF


Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557